May 23, 2012 — Accumetrics Inc., developer of the VerifyNow System, the first rapid and easy-to-use point-of-care system ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
May 17, 2012 — The U.S. Food and Drug Administration (FDA) today approved generic versions of the blood-thinning drug ...
May 15, 2012 — Reaching out to patients with a few simple phone calls significantly improves the likelihood they’ll ...
As an editor for DAIC and Imaging Technology News, I am a third-party observer in the cardiac and radiology markets. I ...
April 24, 2012—Providing more guidance to clinicians on the provision of optimal patient care, the American College of ...
April 19, 2012 — Spherix Inc. announced results from its recently completed studies using near-infrared spectroscopy on ...
April 6, 2012 — The U.S. anticoagulant market is on the verge of a major shift in clinical practice, transitioning from ...
April 2, 2012 — It seems a picture is worth more than a thousand words for people who see evidence of coronary artery ...
March 29, 2012 — Internet-based telemedicine systems appear to lead to more appropriate and effective pharmacotherapy ...
March 29, 2012 — Adding vorapaxar, an investigational platelet blocker, to standard antiplatelet therapy significantly ...
March 29, 2012 — A three-pronged intervention in Brazilian public hospitals significantly improved physician adherence ...
March 27, 2012 – Researchers found the antiplatelet drug abciximab significantly decreased damage to the heart muscle in ...
March 19, 2012 – Individuals suffering from chronic heart failure (CHF) can look forward to the appearance of many new ...
March 9, 2012 — Researchers say venom from the green mamba snake may aid in the preservation of cardiac and renal ...
March 8, 2012 — Transgenomic Inc. announced the publication of a new study by researchers at Vanderbilt University that ...